Belite Bio (BLTE): CFO reported a transaction in 10K shares
Hao-yuan Chuang, CFO at Belite Bio, reported a transaction of 10K shares.
- 10K
- Shares
- Traded
- Apr 21, 2026
- Filed
- Apr 24, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 9, 2026Insider · 3 peopleInsiders: 9 sales (~$3.0M)
- Apr 15, 2026Insider · 1 personInsiders: 5 sales (~$168K)
- Apr 16, 2026Insider · 1 personInsiders: 7 sales (~$160K)
- Apr 17, 2026Insider · 1 personInsiders: 6 sales (~$162K)
- Apr 20, 2026Insider · 1 personInsiders: 7 sales (~$164K)
- Apr 21, 2026Insider · 1 personInsiders: 5 sales (~$166K)
What came next
- Apr 22, 2026Insider · 1 personInsiders: 9 sales (~$170K)
- Apr 23, 2026Insider · 1 personInsiders: 6 sales (~$166K)
- Apr 24, 2026Insider · 1 personInsiders: 6 sales (~$160K)
- Apr 27, 2026Insider · 1 personInsiders: 5 sales (~$163K)
- Apr 28, 2026Insider · 1 personInsiders: 9 sales (~$159K)
- Apr 29, 2026Insider · 1 personInsiders: 5 sales (~$156K)
- Apr 30, 2026InsiderOfficer sold ~$6.5K of BLTE shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Belite Bio
For Belite Bio, OQRO holds 46 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BLTE page.
Other recent filings by Hao-yuan Chuang, Chief Financial Officer
- SEC Form 4 at Belite Bio (BLTE)Sep 10, 2026
- SEC Form 4 at Belite Bio (BLTE)Sep 10, 2026
- SEC Form 4 at Belite Bio (BLTE)Sep 10, 2026
- SEC Form 4 at Belite Bio (BLTE)Sep 10, 2026
- SEC Form 4 at Belite Bio (BLTE)Sep 10, 2026
The full history of Hao-yuan Chuang, Chief Financial Officer is on the profile page.
How this filing works
Explore the data
Other disclosures at Belite Bio
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
- SEC Form 4Oct 6, 2026
Everything OQRO holds on this company is on its BLTE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data